About Nectero Medical
Nectero Medical is a private company based in Tempe, Arizona. It has reported $50,981,047 raised in three offerings on Form D since April 2020. Its chief executive is Jack Springer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 2024 | May 10, 2024 | $32,791,551of $96.6M target | 30 | $1.0M | Equity, Series D Preferred StockRule 506(b) | Form D ↗ |
| Aug 16, 2021 | Sep 1, 2021 | $18,189,496fully sold | 31 | $586K | EquityRule 506(b) | Form D ↗ |
| Not yet | Apr 30, 2020 | $0of $1.5M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $50,981,047 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nectero Medical's Form D filed May 10, 2024.
AD
Anil Dasu
Director
CM
Colin Morrison
Director
BZ
Bryan Ziegler
Chief Financial Officer
BR
Bruce Roberts
Director
JS
Jack Springer
President and Chief Executive Officer, director
RW
Robert Whirley
Director
Earlier filings also listed John Springer (executive officer and director, last listed Sep 2021).